Trial · NCT00410761
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Progression-Free Survival(PFS) | Vandetanib 300 mg | 30.5 | 95% Confidence Interval NA to NA | Months | |
| Progression-Free Survival(PFS) | Placebo | 19.2 | 95% Confidence Interval NA to NA | Months | |
| Objective Response Rate (ORR) | Vandetanib 300 mg | 104 | Participants | ||
| Objective Response Rate (ORR) | Placebo | 13 | Participants | ||
| Disease Control Rate (DCR) | Vandetanib 300 mg | 200 | Participants | ||
| Disease Control Rate (DCR) | Placebo | 71 | Participants | ||
| Duration of Response (DoR) | Vandetanib 300 mg | 22.2 | 95% Confidence Interval NA to NA | Months | |
| Duration of Response (DoR) | Placebo | 16.3 | 95% Confidence Interval NA to NA | Months | |
| Overall Survival (OS) | Vandetanib 300 mg | 81.6 | 95% Confidence Interval 64.6 to 98.5 | Months | |
| Overall Survival (OS) | Placebo | 80.4 | 95% Confidence Interval 52.5 to NA | Months | |
| Biochemical Response Calcitonin (CTN) | Vandetanib 300 mg | 160 | Participants | ||
| Biochemical Response Calcitonin (CTN) | Placebo | 3 | Participants | ||
| Biochemical Response Carcinoembryonic Antigen (CEA) | Vandetanib 300 mg | 119 | Participants | ||
| Biochemical Response Carcinoembryonic Antigen (CEA) | Placebo | 2 | Participants | ||
| Time to Worsening of Pain (TWP) | Vandetanib 300 mg | 7.85 | 95% Confidence Interval 5.39 to 12.16 | Months | |
| Time to Worsening of Pain (TWP) | Placebo | 3.25 | 95% Confidence Interval 1.87 to 5.26 | Months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00410761/results